Cardiotoxicity prevention trials in the era of contemporary cancer therapies: a systematic review
Related Posts
Keamy-Minor E, Dudum R, Bragdon CL, Ngo S, Xu S, Asch SM, Maron DJ, Brown-Johnson C, Sandhu AT, Rodriguez F. NOTIFY-DISCUSS: Patient and clinician perspectives[...]
Shin J, Hong J, Hong SG, Cho J, Johnson BD, Cherepanova OA, Kim CH. Impact of TLR3 activation on endothelial functions: insights into iNOS-dependent mechanisms.[...]
Lakshmanan S, Wang Y, Chen YQ, Mancini GJ, Leipsic J, Budoff M, Hague C, Min JK, Stone GW, Boden WE, Spertus JA, Bangalore S, Hochman[...]